Johnson & Johnson was in the courtroom quite often last year. Bloomberg News (3/28, Fisk, Feeley, 2.41M) just reported that J&J “had a year for the record books – it lost six of last year’s seven largest jury verdicts in the US over product defect claims. Now in 2017, things are looking much the same for this household company name. The report by Bloomberg states that Johnson & Johnson has at least 17 more pending trials in both state and federal US courts. Everything from hip implants, talcum powder, pelvic mesh and a blood thinner are among those claims. Bloomberg reports that it’s unusual for “companies to get hit with more than two or three product defect verdicts above $20 million in any given year,” but J&J “lost six of more than $50 million.”
Author: Sarah Showardhttp://showardlaw.com
Sarah Showard graduated from the University of Maryland in 1985, Magna Cum Laude with a Bachelor of Arts in English-Linguistics and a Certification in Women's Studies. She then graduated from New York University School of Law in 1988. Sarah began practice initially as an insurance defense attorney, and has been representing plaintiffs since 1990.